Navigation Links
LaVoie Group Adds Cancer Therapeutics Company, Neotropix(R),to Its Life Science Agency Roster
Date:9/29/2008

SALEM, Mass., Sept. 29 /PRNewswire/ -- LaVoie Group, a full-service provider of public relations, investor relations, corporate communications, and marketing strategy to life science clients, today announced that it has been selected as public relations agency of record by cancer therapeutics company, Neotropix(R), Inc.

Donna L. LaVoie, President & CEO of LaVoie Group, commented, "We are delighted to represent Neotropix during an important stage in the company's clinical development. Neuroendocrine cancers are difficult to treat and Neotropix has developed an innovative treatment approach that warrants further clinical development and financing. We look forward to working with the Company to communicate its message to appropriate investors, media, pharmaceutical partners and physicians."

About Neotropix(R)

Neotropix(R), Inc., is focused on the development of anti-cancer products that have a high degree of selectivity for tissues resulting in both therapeutic efficacy and an excellent safety and tolerability profile. Neotropix(R) develops and commercializes systemically deliverable oncolytic viruses for the treatment of solid tumors. Capitalizing on its unique sources of naturally occurring viruses that selectively target tumors discovered using the company's proprietary technology platform Viruscreen(TM), the Company has the knowledge and skills to translate these discoveries into commercial products. Neotropix(R) is committed to making a difference in the lives of cancer patients.

Neotropix(R) commenced operations in 2005 in Malvern, Pennsylvania and is venture-capital-funded company by investors including Aurora Funds, Quaker BioVentures and VIMAC Ventures. For more information, please visit http://www.neotropix.com .

About LaVoie Group, Inc.

LaVoie Group provides senior level strategic counsel and tactical implementation of public, investor and corporate communications programs designed to properly position, create visibility and drive value for each client. Our clients range from privately held start-ups to industry leaders in life sciences. For more information, please visit http://www.lavoiegroup.com.


'/>"/>
SOURCE LaVoie Group
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. LaVoie Group Adds Two New Companies to Its Life Science Client Roster
2. LaVoie Group Adds Interleukin Genetics to its Life Science Agency Roster
3. Broad-based group of physicians calls for improvement in stroke treatment
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
6. HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure
7. New Research Uncovers how to Build and Maintain an Effective Competitive Intelligence Group
8. AMERIGROUP to Acquire Memphis Health Plan
9. Securians Minnesota Life Continues to Climb Group Life Rankings
10. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
11. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2017)... ... May 27, 2017 , ... From May 21-23, hearing healthcare professionals gained ... was held at the Marriott Syracuse Downtown Hotel in Syracuse, New York. , ... of independent hearing healthcare providers to help them stay ahead in the industry. At ...
(Date:5/26/2017)... ... May 26, 2017 , ... Mediaplanet is proud to ... campaign in USA Today, which will educate readers on how to take care of ... a large focus is placed on melanoma. Dancing with the Stars professional, Witney Carson, ...
(Date:5/26/2017)... ... May 26, 2017 , ... Leading CEOs ... on May 30th and 31st at The Four Seasons Hotel Boston. , ... the life sciences, offering exclusive access to key decision makers who influence deal ...
(Date:5/26/2017)... ... ... Amir Qureshi, MD is the first physician in Arkansas to implant Nuvecta’s ... Nuvectra™ Algovita SCS System has been FDA approved as a treatment option for chronic ... introduce the most powerful SCS system and the only stretchable lead on the market. ...
(Date:5/26/2017)... ... May 26, 2017 , ... A new analysis of community ... healthiest seniors are located in the Midwest. With the average cost of healthcare rising ... are concerned with both the quality and affordability of where they live. An annual ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)... , May 17, 2017  Bayer announced today ... portfolio will be presented at the 53 rd ... (ASCO), taking place June 2-6 in Chicago ... at ASCO span prostate, colorectal, liver and thyroid cancers, ... from the Phase II CHRONOS-1 trial of copanlisib in ...
(Date:5/10/2017)... Hologic, Inc. (Nasdaq: HOLX ) announced today ... ended April 1, 2017 .   GAAP diluted earnings ... the prior year period as the sale of the ... non-GAAP diluted EPS of $0.50 increased 6.4%.  Revenue of ... terms.  Excluding the effects of blood screening and the ...
(Date:5/9/2017)... Ind. , May 9, 2017 Zimmer ... leader in musculoskeletal healthcare, today announced it has earned ... Employers of 2017" list. The Company was ranked among ... of Large Employers and Healthcare Equipment and Services. ... employers based on an anonymous, independent survey of over ...
Breaking Medicine Technology: